Profit Margin (Quarterly) Chart

View Profit Margin (Quarterly) for GMED.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Profit Margin (Quarterly) Chart
Start Trial

Historical Profit Margin (Quarterly) Data

View and export this data back to 2011. Start Trial.
Date Value
June 30, 2026 19.20%
March 31, 2026 16.36%
December 31, 2025 17.01%
September 30, 2025 15.47%
June 30, 2025 27.22%
March 31, 2025 12.62%
December 31, 2024 4.03%
September 30, 2024 8.28%
June 30, 2024 5.04%
March 31, 2024 -1.17%
December 31, 2023 2.44%
September 30, 2023 0.26%
June 30, 2023 19.79%
March 31, 2023 17.76%
December 31, 2022 18.24%
September 30, 2022 18.66%
June 30, 2022 20.71%
March 31, 2022 16.52%
December 31, 2021 6.04%
September 30, 2021 20.55%
June 30, 2021 16.55%
March 31, 2021 19.94%
December 31, 2020 22.68%
September 30, 2020 20.46%
June 30, 2020 -13.99%
Date Value
March 31, 2020 13.62%
December 31, 2019 21.51%
September 30, 2019 19.52%
June 30, 2019 19.62%
March 31, 2019 18.15%
December 31, 2018 18.76%
September 30, 2018 20.80%
June 30, 2018 25.94%
March 31, 2018 22.67%
December 31, 2017 13.85%
September 30, 2017 16.86%
June 30, 2017 18.81%
March 31, 2017 18.43%
December 31, 2016 16.03%
September 30, 2016 19.33%
June 30, 2016 18.77%
March 31, 2016 20.11%
December 31, 2015 26.37%
September 30, 2015 19.33%
June 30, 2015 18.01%
March 31, 2015 18.73%
December 31, 2014 21.46%
September 30, 2014 19.58%
June 30, 2014 18.18%
March 31, 2014 18.51%

Profit Margin Definition

Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.

Read full definition.

Profit Margin (Quarterly) Range, Past 5 Years

View Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Profit Margin (Quarterly) Benchmarks

View Profit Margin (Quarterly) Benchmarks
Start Trial
Teleflex, Inc. 7.32%
The Cooper Cos., Inc. -7.20%
Intuitive Surgical, Inc. 28.46%
Stryker Corp. 19.37%
Zimmer Biomet Holdings, Inc. 9.17%